Overview

Implantable Pulse Generator Market Introduction

Implantable pulse generator is a medical device that is battery-powered and when implanted in the body, it electrically stimulates the nervous system so that different nerve impulses in the body are either blocked or stimulated. This technology is a promising treatment for various medical conditions like hypertension, reducing back pain, curing diabetes to stop dosage of insulin taken on a daily basis and obesity. Implantable pulse generator can also be used in cases where medicines are either showing some side effects or are completely ineffective.

Implantable pulse generator is programmed to provide electric stimuli to nervous systems and essential for neuro-modulation. The rapid advancement of technologies integrated the multiple parameters and increased demand among the end user segment. Further, changing life pattern increased the prevalence of chronic disorders and fuelled the growth of the market. Neuromodulation is a novel method of a prosthesis for better management of disease prognosis. They are proven effective and safe compared to the traditional method of treatments. Along with this, growing research initiatives like European human brain project and US brain research activities are expected to advance the neuro-technologies. Further, increasing financial investments by top tier manufacturers led to rapid growth of the market.

North America market is expected to witness high market share in global market due to adoption of Neuromodulation in disease management. It is dominated the US due to strong intensity of top tier manufacturers. It is followed by the European region and it accounts a significant share in the global market due to supportive regulations. Asia-Pacific region is the third major shareholder in the global market due to increasing research activities. Latin America represented a fast growing region in global market due to rising awareness among end-user segment. Rest of World accounts the small fraction of market share due to less adoption.

Implantable Pulse Generator market players include:

Abbott, Nevro Corporation, BioControl Medical, Scientific, Integer Holdings Corporation, Medtronic Inc., Synapse Biomedical, Inc., and others

Implantable Pulse Generator Market Trends, Share and Size

Implantable Pulse Generator Market Segmentation

By Product Type

+ Rechargeable

+ Non-rechargeable

By Device Placement Type
+ Spine
+ Heart

By Application
+ Chronic arrhythmia
+ Hypertension
+ Diabetes

By End User

+ Hospitals

+ Clinics

+ Outpatient Centres

+ Homecare Settings

By Region

+ North America

+ Latin America

+ Europe

+ Asia Pacific

+ Rest of the World

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global Implantable Pulse Generator Market by Product Type, by End User, by Region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies